Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AEZS | D | AEterna Zentaris Inc. | 4.00 | |
AFMD | F | Affimed Therapeutics B.V. | 0.19 | |
AGE | C | AgeX Therapeutics, Inc. | 0.00 | |
AGRX | F | Agile Therapeutics, Inc. | 10.78 | |
ALNY | F | Alnylam Pharmaceuticals, Inc. | 1.59 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 1.05 | |
APRE | D | Aprea Therapeutics, Inc. | 2.53 | |
RCUS | D | Arcus Biosciences, Inc. | 9.37 | |
ATRA | F | Atara Biotherapeutics, Inc. | 5.90 | |
AUPH | F | Aurinia Pharmaceuticals Inc | 1.42 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | B | Simplify Health Care ETF | 9.04 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 6.95 | |
BBP | D | BioShares Biotechnology Products Fund | 6.63 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 4.77 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 4.46 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles